Signant Health

What Signant Health does

Signant Health is a privately held clinical trial technology provider headquartered in Blue Bell, Pennsylvania, serving pharmaceutical sponsors, contract research organizations, and biotech companies across North America, Europe, and Asia-Pacific. The company delivers a unified eClinical platform called SmartSignals that integrates electronic clinical outcome assessment (eCOA), electronic data capture (EDC), randomization and trial supply management (RTSM), eConsent, supply chain software, telemedicine, and the PureSignal analytics layer, supporting traditional, decentralized, and hybrid trial designs. With over 1,000 employees, a scientific bench of 50+ in-house clinicians and scientists, and a customer base of 600+ sponsors and CROs including all Top 20 pharma companies, Signant Health reports involvement in clinical trials associated with 25-28% of FDA and EMA novel drug approvals since 2017.

The company's revenue model is a hybrid of SaaS-style subscription licensing for the SmartSignals platform (sold per-study or as enterprise licenses) and professional services revenue from COA strategy, rater training and qualification, and protocol design consulting. Go-to-market relies on enterprise field sales to large pharma and CROs, supplemented by channel partnerships — most notably the September 2024 IQVIA One Home for Sites integration — and a CRO partnership network. The May 2026 acquisition of Ametris (formerly ActiGraph) and January 2025 acquisition of Biofourmis Connect extended the platform into wearable-derived digital biomarkers and remote patient monitoring, enabling the combination of subjective patient-reported outcomes with objective sensor data on a single provider stack.

Signant Health has executed an active inorganic growth strategy, having acquired CRF Health in 2018, VirTrial in 2020, DSG Inc. in 2023, Biofourmis Connect in 2025, and Ametris in 2026. Recent leadership additions include a Chief Commercial Officer (July 2024), Chief Financial Officer (December 2024), and Clinical Vice Presidents in CNS/Alzheimer's and metabolic disease (2025-2026), consistent with a company scaling enterprise operations. The privately held firm is backed by Genstar Capital and Harvest Partners Structured Capital (per 2018 disclosures), operates globally with engineering hubs in Helsinki and Hyderabad, and competes in the eClinical solutions market reported at $12.23 billion in 2025.

Name

Signant Health

Legal name

Signant Health Holding Corp.

Website

https://signanthealth.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Clinical Trial Technology / eClinical Solutions

NAICS

Computer Systems Design Services (541512), Scientific Research and Development Services (5417)

SIC

Services-Prepackaged Software (7372), Services-Management Consulting Services (8742)

akta.pro primary industry

DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)

akta.pro secondary industry

Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)

Keywords

• Clinical trial software
• Electronic data capture
• Electronic clinical outcomes
• Patient engagement solutions
• Clinical supply management

Headquarters

HQ city

Blue Bell

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. eClinical Software Platform: Signant Health generates revenue through SaaS/subscription licensing of its unified eClinical platform (SmartSignals) which includes eCOA, EDC, RTSM, eConsent, and related modules. The platform is sold to pharmaceutical sponsors and CROs on a per-study or enterprise license basis with recurring subscription fees.
2. Clinical Consulting Services: Revenue is generated from scientific and clinical consulting services including protocol design, COA strategy, rater training and qualification, and therapeutic expertise to support evidence generation for clinical trials.
3. Digital Health Technologies: Following the Ametris acquisition, Signant Health offers wearable and sensor-based digital measurement solutions for clinical trials, capturing objective biometric data that complements traditional patient-reported outcomes.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Signant Health provides a unified eClinical platform (SmartSignals) and related services that enable pharmaceutical sponsors and Contract Research Organizations to run traditional, decentralized, and hybrid clinical trials. Its core offerings include electronic clinical outcome assessment (eCOA), electronic data capture (EDC), randomization and trial supply management (RTSM), eConsent, clinical supply chain software, electronic clinician ratings, and advanced analytics, supported by clinical consulting, rater training, and therapeutic-area scientific expertise.

Differentiator

Problem solved

Functional benefit

Brands

• SmartSignals: Unified eClinical platform for clinical data collection including EDC, RTSM, and integrated solutions
• TrialMax
• PureSignal Analytics
• Clinical Data Hub

Products and services

• SmartSignals Unified eClinical Platform Unified platform integrating eCOA, EDC, RTSM, eConsent, and supply chain management for clinical trials, enabling coordinated data flows and seamless workflows across traditional, virtual, and hybrid trial models for pharmaceutical sponsors and CROs.
• eCOA (Electronic Clinical Outcome Assessment) Electronic capture of patient-reported outcomes, clinician ratings, and observer-reported outcomes through provisioned devices or BYOD approaches, supporting endpoints across therapeutic areas for clinical trial sponsors and CROs.
• EDC (Electronic Data Capture) Electronic data capture system that forms part of the unified eClinical platform, enabling direct data entry from clinical sites with real-time data validation and monitoring capabilities for clinical trials.
• RTSM (Randomization and Trial Supply Management) Interactive response technology and supply chain management solution enabling patient randomization, drug dispensation, and inventory management across global trial sites for pharmaceutical sponsors and CROs.
• Supply Chain Software (GxP Inventory) Clinical supply chain management solution providing real-time inventory visibility, temperature excursion management, lot recall capabilities, and integration with manufacturing operations from API to patient for clinical trials.
• Electronic Clinician Ratings / Rater Station Platform for standardized electronic capture of clinician-rated assessments with integrated training, calibration, and quality control features to ensure rating precision and consistency across clinical trial sites.
• PureSignal Analytics Advanced analytics platform providing real-time data quality monitoring, fraud detection, signal identification, and operational insights across clinical trial data streams for sponsors and CROs.
• CDR System (Clinical Data Repository) Centralized data aggregation and intelligence platform that consolidates multi-source clinical data for analysis, reporting, and regulatory submissions across clinical programs.
• eConsent Electronic informed consent platform enabling remote and site-based consent processes with multimedia support, digital signatures, and audit trails for regulatory compliance in clinical trials.
• Telemedicine Virtual visit and remote assessment capabilities supporting decentralized clinical trial conduct with video consultations and remote patient monitoring integration for sponsors and CROs.
• Patient Engagement App Mobile application engaging patients throughout the trial journey with reminders, task management, and direct communication capabilities to improve retention and data quality in decentralized and hybrid trials.
• Digital Health Technologies (Wearable & Sensor Integration) Wearable and sensor-based digital measurement solution that captures objective digital biomarkers and continuous patient monitoring data, combining patient-reported outcomes with biometric sensor data on a unified platform for clinical trials.
• Rater Training and Qualification Professional services offering comprehensive training programs for clinical raters including calibration sessions, certification tracking, and ongoing qualification monitoring to ensure assessment quality in CNS and other complex trials.
• Protocol and Study Design Consulting Scientific and clinical consulting services that help sponsors shape protocol design and measurement strategy to ensure optimal data quality and regulatory acceptance for clinical trials.

Quantifiable outcome

• 25% of novel drug approvals (2021-2024) - Clinical trials associated with Signant Health supported one-quarter of FDA and EMA novel drug approvals
• +2 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature6 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Ametris (formerly ActiGraph)coreTechnology or Integration · 14 May 2026Signant Health completed acquisition of Ametris (formerly ActiGraph) in May 2026, creating a unified platform combining eCOA technology with wearable-based digital measurement systems. The combined entity integrates patient-reported outcomes with continuous sensor data, enabling sponsors to access both subjective and objective biometric data from a single provider.
• SPRIM PROcoreStrategic or Co-development Partner · 30 October 2024Signant Health and SPRIM PRO aligned to advance eClinical solutions, combining SPRIM PRO's expertise with Signant's platform capabilities to enhance evidence generation for clinical trials.
• IQVIAcoreChannel Partner/ Reseller/ Distributor · 4 September 2024Signant Health joined IQVIA's One Home for Sites initiative in September 2024, enabling clinical trial sites to access Signant's SmartSignals platform through a unified portal alongside other eClinical technologies. This collaboration simplifies site conduct in clinical research by providing streamlined access to multiple eClinical solutions.
• ThoughtSphereminorStrategic or Co-development PartnerSignant Health collaborated with ThoughtSphere on a joint webinar exploring how a unified, AI-powered clinical data management solution combining both platforms can streamline data capture, aggregation, and analytics.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Clinical Ink: Clinical Ink provides eCOA, ePRO, and decentralized trial technology directly competing with Signant's TrialMax and patient engagement offerings, particularly in CNS and rare disease trials.
• Castor: Castor offers a cloud-native EDC and eClinical platform with strong user experience focus; an emerging competitor gaining traction in academic and biotech trials that may pressure Signant in mid-market segments.

Direct peers

• Medidata Solutions (Dassault Systèmes): Medidata's Rave platform is the leading enterprise EDC/eCOA/eClinical suite used by large pharma and CROs, directly competing with Signant's SmartSignals across data capture, RTSM, and patient engagement.
• Veeva Systems: Veeva Vault CTMS and Vault EDC compete with Signant's eClinical suite, especially among large pharma sponsors, and Veeva's broader clinical-commercial platform creates bundled competition.
• Clario: Clario is a direct eCOA/ePRO and clinical endpoint technology competitor, formed from the merger of ERT and Bioclinica, and overlaps with Signant's TrialMax eCOA and electronic clinician ratings.
• YPrime: YPrime provides eCOA, IRT, and eClinical platform solutions for clinical trials, directly competing with Signant particularly in mid-sized sponsor and biotech deals.

Broad incumbents

• IQVIA: IQVIA is both a channel partner (One Home for Sites) and a broad incumbent competitor — its Orchestrated Customer Engagement platform and integrated CRO services bundle eClinical technology with full-service execution.
• ICON plc: ICON is a top global CRO with proprietary eClinical technology (including Firecrest and ADDPLAN), competing with Signant through both standalone tech sales and bundled CRO offerings.
• Parexel: Parexel is a major CRO with significant technology-enabled trial offerings, competing with Signant for enterprise pharma business through integrated service plus platform deals.
• Oracle Health Sciences (Clinical One / Inform): Oracle's Clinical One platform and legacy Phase Forward/InForm EDC compete with Signant in enterprise pharma, leveraging Oracle's broader cloud and data infrastructure footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/SignantHealth
• Facebookfacebook.com/actitrainer
• LinkedInlinkedin.com/company/signant-health
• Instagraminstagram.com/explore/tags/signanthealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Signant Health